<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="68868">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01977040</url>
  </required_header>
  <id_info>
    <org_study_id>OBX 0025</org_study_id>
    <nct_id>NCT01977040</nct_id>
  </id_info>
  <brief_title>Optimal Management of Vasa Previa Study - A Retrospective Study</brief_title>
  <acronym>VasaPrevia</acronym>
  <official_title>Optimal Management of Vasa Previa: Screening, Diagnosis and Management - A Retrospective Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Obstetrix Medical Group</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Obstetrix Medical Group</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicenter retrospective observational study of women diagnosed with a vasa
      previa during pregnancy or at delivery who delivered between 2000 and 2012.  The study hopes
      to be able to describe techniques utilized to screen for and diagnose vasa previa as well as
      to describe the maternal characteristics and identify potential underlying risk factors that
      may provide a basis for future screening recommendations for vasa previa and treatment
      protocols.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter retrospective study of women identified as having a vasa previa during
      pregnancy or at the time of delivery who delivered between January 1, 2000 and December 31,
      2012 at participating centers.  The primary objective of the study is to describe techniques
      utilized to screen for and diagnose vasa previa.

        -  In those cases that were diagnosed antenatally, to describe the different management
           protocols utilized, correlate these management protocols with neonatal outcomes and
           support the management protocol that offers optimal outcomes for both mother and
           neonate.

        -  In those cases that were not diagnosed antenatally, to describe the clinical scenario
           surrounding delivery and the neonatal outcomes.  Review the ultrasound reports and
           maternal characteristics to identify any potential risk factors for vasa previa that
           could have been identified antenatally in attempt to improve neonatal outcomes in the
           future.

        -  In all cases of diagnosed vasa previa (those diagnosed antepartum, intrapartum, and
           postpartum), to describe the maternal characteristics and identify potential underlying
           risk factors that may provide a basis for future screening recommendations and
           protocols. Due to the rarity of this diagnosis, the study hopes to include 100-250
           participants.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>Techniques utilized to screen for and diagnose vasa previa during pregnancy.</measure>
    <time_frame>Participants will be followed from time of diagnosis of vasa previa until the baby is born, an expected time frame of 9 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The primary outcome of the study it to describe techniques utilized to screen for and diagnose vasa previa:
In cases diagnosed during pregnancy, to describe and correlate management protocols with neonatal outcomes
In cases diagnosed during pregnancy, to describe the clinical scenario surrounding delivery and neonatal outcome that might ultimately leading to improved neonatal outcome.
In all cases of diagnosed vasa previa, to describe the maternal characteristics and identify potential underlying risk factors that may provide a basis for future screening recommendations and protocols.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Vasa Previa</condition>
  <arm_group>
    <arm_group_label>Vasa Previa</arm_group_label>
    <description>Women with the diagnosis of Vasa Previa made during the pregnancy or at time of delivery who delivered between January 1, 2000 and December 31, 2012.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Women at participating site who have been identified as having a vasa previa between
        January 1, 2000 and December 31, 2012.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with the diagnosed of vasa previa made either during the pregnancy via
             ultrasound or at time of delivery via clinical and/or pathologic investigation.

          -  Patient delivered between January 2000 through December 2012

        Exclusion Criteria:

          -  No diagnosis or confirmation of vasa previa

          -  Delivered either before January 1, 2000 or after December 31, 2012
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Garite, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pediatrix Medical Group, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kimberly A Maurel, RN, MSN, CNS</last_name>
    <phone>714-593-9171</phone>
    <email>kimberly_maurel@pediatrix.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Diana Abril, RN, MS, CRM</last_name>
    <phone>480-659-8644</phone>
    <email>diana_abril@pediatrix.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of South Alabama Medical Center</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36617</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Lewis, MD</last_name>
      <phone>251-415-1598</phone>
      <email>davidlewis@usouthal.edu</email>
    </contact>
    <contact_backup>
      <last_name>Casey Armestead</last_name>
      <phone>251-415-1598</phone>
      <email>marmestead@usouthal.edu</email>
    </contact_backup>
    <investigator>
      <last_name>David Lewis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Banner Desert Medical Center</name>
      <address>
        <city>Mesa</city>
        <state>Arizona</state>
        <zip>85210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ana B Braescu, RN, MSN</last_name>
      <phone>602-257-8118</phone>
      <phone_ext>135</phone_ext>
      <email>Ana_braescu@PEDIATRIX.COM</email>
    </contact>
    <investigator>
      <last_name>Jordan Perlow, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Banner Good Samaritan Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ana V Bodea Braescu, RN, BSN</last_name>
      <phone>602-257-8118</phone>
      <phone_ext>135 or 137</phone_ext>
      <email>ana_braescu@PEDIATRIX.COM</email>
    </contact>
    <contact_backup>
      <last_name>Michelle M Gamez, RN</last_name>
      <phone>602-722-9564</phone>
      <email>michelle_gamez@pediatrix.com</email>
    </contact_backup>
    <investigator>
      <last_name>Jordan Perlow, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saddleback Memorial Medical Center</name>
      <address>
        <city>Laguna Hills</city>
        <state>California</state>
        <zip>92653</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Bush, MD</last_name>
      <phone>949-452-7199</phone>
      <email>melissa_bush@pediatrix.com</email>
    </contact>
    <investigator>
      <last_name>Melissa Bush, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Long Beach Memorial Medical Center</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90801-1428</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Nageotte, MD</last_name>
      <phone>562-933-2730</phone>
      <email>Michael_nageotte@pediatrix.com</email>
    </contact>
    <contact_backup>
      <last_name>Deysi Caballero, LVN</last_name>
      <phone>562-933-2730</phone>
      <email>dcaballero@memorialcare.org</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Nageotte, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Good Samaritan Hospital</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95008</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Combs, MD</last_name>
      <phone>408-371-7111</phone>
      <email>andrew_combs@pediatrix.com</email>
    </contact>
    <contact_backup>
      <last_name>Kimberly Mallory, RN</last_name>
      <phone>408-371-7111</phone>
      <email>kimberly_mallory@pediatrix.com</email>
    </contact_backup>
    <investigator>
      <last_name>Andrew Combs, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Presbyterian/St Luke's Hospital</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shira Fishman, MD</last_name>
      <phone>303-860-9990</phone>
      <email>shira_fishman@pediatrix.com</email>
    </contact>
    <contact_backup>
      <last_name>Julie Rael, RN</last_name>
      <phone>303-570-8138</phone>
      <email>julie_rael@pediatrix.com</email>
    </contact_backup>
    <investigator>
      <last_name>Shira Fishman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Hospital, Kansas City</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>George Lu</last_name>
      <phone>816-932-6033</phone>
      <email>glu@saint-lukes.org</email>
    </contact>
    <contact_backup>
      <last_name>Kate Swearingen, WHNP</last_name>
      <phone>816-932-3584</phone>
      <email>kate_swearingen@pediatrix.com</email>
    </contact_backup>
    <investigator>
      <last_name>George Lu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Hospital, Kansas City</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>George Lu</last_name>
      <phone>816-932-6903</phone>
      <email>glu@saint-lukes.org</email>
    </contact>
    <investigator>
      <last_name>George Lu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122-4307</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gorenberg David, MD</last_name>
      <phone>206-386-2101</phone>
      <email>david_gorenberg@pediatrix.com</email>
    </contact>
    <contact_backup>
      <last_name>Tina Lopez, RN</last_name>
      <phone>206-215-3541</phone>
      <email>tina_lopez@pediatrix.com</email>
    </contact_backup>
    <investigator>
      <last_name>Gorenberg David, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 28, 2014</lastchanged_date>
  <firstreceived_date>October 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vasa Previa</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vasa Previa</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
